369 related articles for article (PubMed ID: 20733005)
1. Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor.
An BS; Tavera-Mendoza LE; Dimitrov V; Wang X; Calderon MR; Wang HJ; White JH
Mol Cell Biol; 2010 Oct; 30(20):4890-900. PubMed ID: 20733005
[TBL] [Abstract][Full Text] [Related]
2. SIRT1 enzymatically potentiates 1,25-dihydroxyvitamin D
Sabir MS; Khan Z; Hu C; Galligan MA; Dussik CM; Mallick S; Stone AD; Batie SF; Jacobs ET; Whitfield GK; Haussler MR; Heck MC; Jurutka PW
J Steroid Biochem Mol Biol; 2017 Sep; 172():117-129. PubMed ID: 28636886
[TBL] [Abstract][Full Text] [Related]
3. The Tumor Suppressor FBW7 and the Vitamin D Receptor Are Mutual Cofactors in Protein Turnover and Transcriptional Regulation.
Salehi-Tabar R; Memari B; Wong H; Dimitrov V; Rochel N; White JH
Mol Cancer Res; 2019 Mar; 17(3):709-719. PubMed ID: 30606768
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor as a master regulator of the c-MYC/MXD1 network.
Salehi-Tabar R; Nguyen-Yamamoto L; Tavera-Mendoza LE; Quail T; Dimitrov V; An BS; Glass L; Goltzman D; White JH
Proc Natl Acad Sci U S A; 2012 Nov; 109(46):18827-32. PubMed ID: 23112173
[TBL] [Abstract][Full Text] [Related]
5. Role of SIRT1 and FOXO factors in eNOS transcriptional activation by resveratrol.
Xia N; Strand S; Schlufter F; Siuda D; Reifenberg G; Kleinert H; Förstermann U; Li H
Nitric Oxide; 2013 Aug; 32():29-35. PubMed ID: 23583951
[TBL] [Abstract][Full Text] [Related]
6. Actions of 1,25(OH)2-vitamin D3 on the cellular cycle depend on VDR and p38 MAPK in skeletal muscle cells.
Irazoqui AP; Boland RL; Buitrago CG
J Mol Endocrinol; 2014 Dec; 53(3):331-43. PubMed ID: 25316911
[TBL] [Abstract][Full Text] [Related]
7. SIRT1-FOXO3a regulate cocaine actions in the nucleus accumbens.
Ferguson D; Shao N; Heller E; Feng J; Neve R; Kim HD; Call T; Magazu S; Shen L; Nestler EJ
J Neurosci; 2015 Feb; 35(7):3100-11. PubMed ID: 25698746
[TBL] [Abstract][Full Text] [Related]
8. The evolutionarily conserved longevity determinants HCF-1 and SIR-2.1/SIRT1 collaborate to regulate DAF-16/FOXO.
Rizki G; Iwata TN; Li J; Riedel CG; Picard CL; Jan M; Murphy CT; Lee SS
PLoS Genet; 2011 Sep; 7(9):e1002235. PubMed ID: 21909281
[TBL] [Abstract][Full Text] [Related]
9. 1alpha,25-Dihydroxyvitamin D(3) antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21(waf1) upregulation in human osteosarcoma.
Wu W; Zhang X; Zanello LP
Cancer Lett; 2007 Aug; 254(1):75-86. PubMed ID: 17412493
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol potentiates vitamin D and nuclear receptor signaling.
Dampf Stone A; Batie SF; Sabir MS; Jacobs ET; Lee JH; Whitfield GK; Haussler MR; Jurutka PW
J Cell Biochem; 2015 Jun; 116(6):1130-43. PubMed ID: 25536521
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells.
Egan JB; Thompson PA; Vitanov MV; Bartik L; Jacobs ET; Haussler MR; Gerner EW; Jurutka PW
Mol Carcinog; 2010 Apr; 49(4):337-52. PubMed ID: 20043299
[TBL] [Abstract][Full Text] [Related]
12. Stat1-vitamin D receptor interactions antagonize 1,25-dihydroxyvitamin D transcriptional activity and enhance stat1-mediated transcription.
Vidal M; Ramana CV; Dusso AS
Mol Cell Biol; 2002 Apr; 22(8):2777-87. PubMed ID: 11909970
[TBL] [Abstract][Full Text] [Related]
13. Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down.
Costa JL; Eijk PP; van de Wiel MA; ten Berge D; Schmitt F; Narvaez CJ; Welsh J; Ylstra B
BMC Genomics; 2009 Oct; 10():499. PubMed ID: 19863778
[TBL] [Abstract][Full Text] [Related]
14. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.
Zinser GM; McEleney K; Welsh J
Mol Cell Endocrinol; 2003 Feb; 200(1-2):67-80. PubMed ID: 12644300
[TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D3 and the aging-related forkhead box O and sestrin proteins in osteoblasts.
Eelen G; Verlinden L; Meyer MB; Gijsbers R; Pike JW; Bouillon R; Verstuyf A
J Steroid Biochem Mol Biol; 2013 Jul; 136():112-9. PubMed ID: 22989484
[TBL] [Abstract][Full Text] [Related]
16. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention.
Bartik L; Whitfield GK; Kaczmarska M; Lowmiller CL; Moffet EW; Furmick JK; Hernandez Z; Haussler CA; Haussler MR; Jurutka PW
J Nutr Biochem; 2010 Dec; 21(12):1153-61. PubMed ID: 20153625
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist.
Tavera-Mendoza LE; Quach TD; Dabbas B; Hudon J; Liao X; Palijan A; Gleason JL; White JH
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8250-5. PubMed ID: 18550844
[TBL] [Abstract][Full Text] [Related]
18. Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress.
Hori YS; Kuno A; Hosoda R; Horio Y
PLoS One; 2013; 8(9):e73875. PubMed ID: 24040102
[TBL] [Abstract][Full Text] [Related]
19. Genomically anchored vitamin D receptor mediates an abundance of bioprotective actions elicited by its 1,25-dihydroxyvitamin D hormonal ligand.
Haussler MR; Haussler CA; Jurutka PW
Vitam Horm; 2023; 123():313-383. PubMed ID: 37717990
[TBL] [Abstract][Full Text] [Related]
20. 1,25-Dihydroxyvitamin D(3) regulates PTHrP expression via transcriptional, post-transcriptional and post-translational pathways.
Bhatia V; Mula RV; Falzon M
Mol Cell Endocrinol; 2011 Aug; 342(1-2):32-40. PubMed ID: 21664243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
